Invacare makes progress during ‘most challenging year’

Invacare makes progress during 'most challenging year'

Ohio-based medical device maker Invacare (NYSE:IVC) jumped a few points today, despite posting a tough 2nd quarter, as the company reported progress in emerging from an FDA consent decree that has limited research, development and manufacturing abilities.

Invacare’s Q2 2013 sales dropped 5.6% compared with the same period last year, and losses more than tripled in the 3 months ended June 30, 2013. Nonetheless, IVC shares jumped 4.8% today, trading at $16.40 as of about 1:30 p.m.

Invacare has since last year been operating under an FDA order that temporarily shuttered 2 manufacturing facilities and forced the company to divest its medical supplies business. The FDA in December 2012 said that it had flagged problems with Invacare’s quality control system over 7 inspections since 2002, "along with failures to properly report adverse events to the agency."

Invacare’s corporate headquarters and a wheelchair manufacturing facility were largely shut down and ordered to undergo 3rd-party inspections to demonstrate compliance with FDA manufacturing guidelines. The device maker managed to eke out a modest profit in Q2, despite struggling through a year that CEO Gerald Blouch called "1 of the most challenging in the company’s history."

Earlier this month Invacare announced that it was permitted to resume design activities at headquarters and at the manufacturing facility, having won a partial go-ahead from the FDA and getting one step closer to exiting the injunction phase of the consent decree. The device maker said it planned to ramp up wheelchair and power bed design operations and that it will keep investors updated on the final of 3 certification reports mandated by the FDA, which Invacare said it expects to file mid-November.

"We have made significant investments to ensure we have a comprehensive and sustainable compliance environment, and the verification of the expert auditor combined with the FDA’s acceptance of the 1st 2 certification reports confirm that we are on the right track," Blouch said in prepared remarks. "Nevertheless, our financial results continue to be significantly impacted by the consent decree, which limits the company’s ability to manufacture high-margin, custom power wheelchair products at our Taylor Street facility in Elyria, Ohio, and ongoing costs related to improvements to our quality system."

Invacare reported losses of $9.3 million, or 29¢ per diluted share, on revenues of $351.8 million during the 2nd quarter. That compared with losses of $2 million, or 7¢ per share, on sales of $372.7 million during the same period last year.

Adjusted to exclude 1-time expenses, the device maker posted per-share losses of 27¢, compared to analysts’ consensus estimate of 20¢ in per-share losses.

RSS From Medical Design & Outsourcing

  • Albright Technologies expands their silicone offerings
    Albright Technologies, a rapid silicone prototyper, has added silicone injection molding tooling and services to its product lineup. Liquid silicone injection molding became a suitable product offering as Albright expanded its offerings to better serve the silicone molding market. While silicone prototypes are commonly manufactured with low volumes in mind; injection molded liquid silicone rubber parts are […]
  • Applied Silver launches SilvaClean, silver treatment for textiles
    Applied Silver, Inc, is launching SilvaClean, a state-of-the-art silver treatment for textiles, at the Association for Professionals in Infection Control and Epidemiology’s (APIC) forty-second Annual Conference taking place at the Music City Center in Nashville, from June 27 through June 29. Hospitals have invested significantly in reducing the potential of infection through products and processes designed […]
  • Two-Component technology for improved quality of life
    In the field of injection molding and mold making, toolcraft covers all processes within the added value chain–from the design and selection of materials through to the creation of finished and qualified products. Complete solutions offered include injection molding for parts in the small and extremely small component areas, e.g. for medical technology. Utilizing two-component […]
  • GDS security protects medical devices from hackers
    As data breaches become more commonplace with serious consequences to personal, corporate and national security, it is clear that there is no shortage of accomplished and effective hackers ready to steal data and trade it on the open market. Global Data Sentinel (GDS) has the ability to provide retroactive security to remove access to email […]
  • BRAEBON and SomnoMed combine products to combat sleep apnea
    BRAEBON Medical Corporation announces that the DentiTrac oral appliance compliance system has passed a regulatory hurdle and is now FDA cleared in the USA for use with the SomnoDent oral device. BRAEBON congratulates SomnoMed for being the first company to achieve this milestone. “We are pleased DentiTrac is launching in the US market. Accurate oral appliance […]
  • For advanced shielded plastic connector solution, ODU delivers with latest product
    ODU, a company which designs and manufactures connector solutions and cable assemblies, is announcing ODU MEDI-SNAP EMC, the advanced shielded plastic connector solutions, to the US market. ODU MEDI-SNAP EMC is the latest addition to ODU’s Push-Pull circular connectors. The advanced medical connector solution is lightweight, autoclavable, sterilizable and it offers a touch proofed housing and reliable […]
  • LifeVac steps towards availability on European markets
    On June 16, 2015, LifeVac Europe received confirmation from the UK Ministry of Health that LifeVac is now registered in the Medicines and Healthcare products Regulatory Agency public access data base. This is the final step towards acquiring the CE mark and making LifeVac available to the entire European market. “We are very excited to […]
  • A few ideas for improving productivity in medical processes
    Drive-based vibration and slosh control can help improve throughput in machines that assemble medical devices and products. Bipin Sen • Ed Lasch Bosch Rexroth Corporation www.boschrexroth-us.com Simply increasing the speed of a system that assembles medical devices, or packages medical products, seems like an easy way to boost throughput – until unwanted vibration (either induced […]
  • ODU announces MEDI-SNAP EMC for next generation medical applications
    ODU, announced ODU MEDI-SNAP EMC, the advanced shielded plastic connector solutions to the US market. ODU MEDI-SNAP EMC is the newest addition to ODU’s Push-Pull circular connectors. The advanced medical connector solution is lightweight, autoclavable, sterilizable and it offers a touch proofed housing and reliable EMI protection at the same time. ODU MEDI-SNAP EMC is available in […]
  • Evaluating the risk of device misconnections: Designing for medical devices with ISO 80369 in mind
    Beginning in the 1990s, concerns grew regarding the proliferation of medical devices fitted with luer connectors and the reports of patient injuries and deaths arising from misconnections. Thus began a many-years process to develop new industry standards for the small-bore connectors used in medical device applications. The much-anticipated ISO 80369 series of standards for small-bore […]
  • Custom molded filter screen assemblies limit contamination and reduce product failure
    Molded screen insert assemblies from Minnesota Rubber and Plastics are custom designed for water, beverage, off-highway and transportation applications to filter out fluid contaminants and reduce product failure. A wide range of screen options are available in many materials for difficult filtration applications allowing use with different fluids. Filter assembly orifice sizes available range from .71 […]

Leave a Reply